skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Potent peptidic fusion inhibitors of influenza virus

Abstract

Influenza therapeutics with new targets and mechanisms of action are urgently needed to combat potential pandemics, emerging viruses, and constantly mutating strains in circulation. We report here on the design and structural characterization of potent peptidic inhibitors of influenza hemagglutinin. The peptide design was based on complementarity-determining region loops of human broadly neutralizing antibodies against the hemagglutinin (FI6v3 and CR9114). The optimized peptides exhibit nanomolar affinity and neutralization against influenza A group 1 viruses, including the 2009 H1N1 pandemic and avian H5N1 strains. The peptide inhibitors bind to the highly conserved stem epitope and block the low pH–induced conformational rearrangements associated with membrane fusion. These peptidic compounds and their advantageous biological properties should accelerate the development of new small molecule– and peptide-based therapeutics against influenza virus.

Authors:
ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ORCiD logo; ; ; ; ORCiD logo; ORCiD logo
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
National Institutes of Health (NIH)
OSTI Identifier:
1408128
Resource Type:
Journal Article
Journal Name:
Science
Additional Journal Information:
Journal Volume: 358; Journal Issue: 6362; Journal ID: ISSN 0036-8075
Publisher:
AAAS
Country of Publication:
United States
Language:
ENGLISH
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Kadam, Rameshwar U., Juraszek, Jarek, Brandenburg, Boerries, Buyck, Christophe, Schepens, Wim B. G., Kesteleyn, Bart, Stoops, Bart, Vreeken, Rob J., Vermond, Jan, Goutier, Wouter, Tang, Chan, Vogels, Ronald, Friesen, Robert H. E., Goudsmit, Jaap, van Dongen, Maria J. P., and Wilson, Ian A. Potent peptidic fusion inhibitors of influenza virus. United States: N. p., 2017. Web. doi:10.1126/science.aan0516.
Kadam, Rameshwar U., Juraszek, Jarek, Brandenburg, Boerries, Buyck, Christophe, Schepens, Wim B. G., Kesteleyn, Bart, Stoops, Bart, Vreeken, Rob J., Vermond, Jan, Goutier, Wouter, Tang, Chan, Vogels, Ronald, Friesen, Robert H. E., Goudsmit, Jaap, van Dongen, Maria J. P., & Wilson, Ian A. Potent peptidic fusion inhibitors of influenza virus. United States. https://doi.org/10.1126/science.aan0516
Kadam, Rameshwar U., Juraszek, Jarek, Brandenburg, Boerries, Buyck, Christophe, Schepens, Wim B. G., Kesteleyn, Bart, Stoops, Bart, Vreeken, Rob J., Vermond, Jan, Goutier, Wouter, Tang, Chan, Vogels, Ronald, Friesen, Robert H. E., Goudsmit, Jaap, van Dongen, Maria J. P., and Wilson, Ian A. Thu . "Potent peptidic fusion inhibitors of influenza virus". United States. https://doi.org/10.1126/science.aan0516.
@article{osti_1408128,
title = {Potent peptidic fusion inhibitors of influenza virus},
author = {Kadam, Rameshwar U. and Juraszek, Jarek and Brandenburg, Boerries and Buyck, Christophe and Schepens, Wim B. G. and Kesteleyn, Bart and Stoops, Bart and Vreeken, Rob J. and Vermond, Jan and Goutier, Wouter and Tang, Chan and Vogels, Ronald and Friesen, Robert H. E. and Goudsmit, Jaap and van Dongen, Maria J. P. and Wilson, Ian A.},
abstractNote = {Influenza therapeutics with new targets and mechanisms of action are urgently needed to combat potential pandemics, emerging viruses, and constantly mutating strains in circulation. We report here on the design and structural characterization of potent peptidic inhibitors of influenza hemagglutinin. The peptide design was based on complementarity-determining region loops of human broadly neutralizing antibodies against the hemagglutinin (FI6v3 and CR9114). The optimized peptides exhibit nanomolar affinity and neutralization against influenza A group 1 viruses, including the 2009 H1N1 pandemic and avian H5N1 strains. The peptide inhibitors bind to the highly conserved stem epitope and block the low pH–induced conformational rearrangements associated with membrane fusion. These peptidic compounds and their advantageous biological properties should accelerate the development of new small molecule– and peptide-based therapeutics against influenza virus.},
doi = {10.1126/science.aan0516},
url = {https://www.osti.gov/biblio/1408128}, journal = {Science},
issn = {0036-8075},
number = 6362,
volume = 358,
place = {United States},
year = {2017},
month = {9}
}

Works referenced in this record:

Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif
journal, October 1999


Structure of influenza haemagglutinin at the pH of membrane fusion
journal, September 1994


A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro.
journal, May 1993


A peptide mimetic of an anti-CD4 monoclonal antibody by rational design
journal, July 2003


Structures of influenza A proteins and insights into antiviral drug targets
journal, April 2010


MolProbity : all-atom structure validation for macromolecular crystallography
journal, December 2009


Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
journal, May 2012


Coot model-building tools for molecular graphics
journal, November 2004


Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
journal, June 2000


Dual Resistance to Adamantanes and Oseltamivir Among Seasonal Influenza A(H1N1) Viruses: 2008–2010
journal, January 2011


The Future of Peptide-based Drugs
journal, December 2012


Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
journal, January 1981


Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
journal, May 2011


PHENIX : building new software for automated crystallographic structure determination
journal, October 2002


Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization
journal, December 2013


Analytical molecular surface calculation
journal, October 1983


Global Transmission of Oseltamivir-Resistant Influenza
journal, March 2009


Cross-neutralization of influenza A viruses mediated by a single antibody loop
journal, September 2012


Antiviral agents active against influenza A viruses
journal, December 2006


Antibody Recognition of a Highly Conserved Influenza Virus Epitope
journal, April 2009


Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
journal, February 2009


Highly Conserved Protective Epitopes on Influenza B Viruses
journal, August 2012


Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
journal, December 2016


Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA
journal, October 2012


Likelihood-enhanced fast translation functions
journal, March 2005


Phaser crystallographic software
journal, July 2007